October 18, 2026 1:27 PM
NPPA caps trade margins on 137 anti-cancer drugs; revised prices effective November 9
The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 identified non-scheduled anti-cancer drugs at 30% of their maximum retail price, a move expected to reduce MRPs by up to 70%, depending on existing price structures. The revised prices will take effect on November 9, under a Gazette notification issued on October 17. The intervention aims to curb excessive distribution and retail margins and ease the financial burden of cancer treatment. The drugs covered incl...